Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution

Md Raisul Kibria, Refo Ilmiya Akbar, Poonam Nidadavolu, Oksana Havryliuk, Sébastien Lafond, Sepinoud Azimi

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Molecular Dynamic (MD) simulations are very effective in the discovery of nanomedicines for treating cancer, but these are computationally expensive and time-consuming. Existing studies integrating machine learning (ML) into MD simulation to enhance the process and enable efficient analysis cannot provide direct insights without the complete simulation. In this study, we present an ML-based approach for predicting the solvent accessible surface area (SASA) of a nanoparticle (NP), denoting its efficacy, from a fraction of the MD simulations data. The proposed framework uses a time series model for simulating the MD, resulting in an intermediate state, and a second model to calculate the SASA in that state. Empirically, the solution can predict the SASA value 260 timesteps ahead 7.5 times faster with a very low average error of 1956.93. We also introduce the use of an explainability technique to validate the predictions. This work can reduce the computational expense of both processing and data size greatly while providing reliable solutions for the nanomedicine design process.
Original languageEnglish
Article number 547
JournalScientific Reports
Volume13
Issue number1
DOIs
Publication statusPublished - 2023
MoE publication typeA1 Journal article-refereed

Fingerprint

Dive into the research topics of 'Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution'. Together they form a unique fingerprint.

Cite this